<DOC>
	<DOCNO>NCT02092454</DOCNO>
	<brief_summary>To assess clinical safety efficacy Benzocaine relative placebo pain relief associate acute otitis medium .</brief_summary>
	<brief_title>Study Assess Safety Efficacy Benzocaine Pain Relief Children Presenting With Acute Otitis Media</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Benzocaine</mesh_term>
	<criteria>Male female patient age 2 month 12 year age clinical diagnosis AOM , ear pain ( current episode &lt; 2 week duration ) . Baseline pain entry require minimum score 4 FLACC FPSR scale ( depend age ) The patient must provide Institutional Review Board ( IRB ) approve write assent , appropriate , must accompany IRB approve write informed consent form ( ICF ) patient 's legally acceptable representative ( i.e. , parent guardian ) , applicable . In addition , patient legally acceptable representative ( i.e. , parent guardian ) must sign Health Insurance Portability Accountability Act ( HIPAA ) authorization , applicable Patients must normally active otherwise judge good health basis medical history limited physical examination , determine Investigator . Females child bear potential must negative urine human chorionic gonadotropin ( hCG ) pregnancy test Visit 1 Patients bilateral AOM , perforate tympanic membrane , history perforate tympanic membrane last 6 month , perforate tympanic membrane could rule speculum examination , impedance test tympanometry , pneumatic otoscopy , Valsalva maneuver Patients subsequently diagnose perforated membrane treatment discontinue immediately . Patients indwell tympanostomy tube drain otitis affect ear ( ) , bullous lesion , erythema tympanic membrane without evidence AOM , patient anatomic defect ear nasopharynx Complications treated/untreated ear disease past 2 week Patients comorbidity require antibiotic therapy , allergy study medication , immunologic deficiency , major medical condition ( ) . Patients methemoglobinemia history methemoglobinemia , vertigo , inherit enzyme deficiency , impaired cardiac respiratory function , epilepsy , heart disease , hypersensitivity , pyrogenic infection near skin , inflame infected skin , dermatitis , shock , hepatic impairment , myasthenia gravis Acute chronic otitis externa Chronic otitis medium ( current episode ≥ 2 week ) Patients smoke prohibit participate study . Seborrheic dermatitis involve affect external ear canal pinna Any topical systemic antibiotic receive within 14 day prior study entry ( topical antibiotic acne allow ) Any topical drying agent overthecounter ( OTC ) therapy otitis medium receive within 36 hour prior enrollment Fever &gt; 102°F Known hypersensitivity study drug similar compound include inactive ingredient Patients receive medication chronic basis pain ( include steroidal nonsteroidal antiinflammatory drug ) Use ear drop oral analgesic ibuprofen/acetaminophen within 4 hour prior study entry Use sulfonamide , aminosalicylates , anti cholinesterase , suxamethonium , antiarrhythmic , monoamine oxidase inhibitor , tricyclic antidepressant Clinically significant mental illness ( determined Investigator ) Exposure investigational agent within 30 day prior study entry Previous enrollment study Pregnant lactate The child condition Investigator believe would interfere ability provide assent ( age appropriate ) comply study instruction , might confound interpretation study result , put child undue risk</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>